Atea Pharmaceuticals Cash from Investing (TTM) Trends

Atea Pharmaceuticals Inc (AVIR)

3.73 -0.01 (-0.27%) USD | NASDAQ | Apr 17, 16:00

3.73 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	40.30M
September 30, 2023	46.02M
June 30, 2023	-382.44M
March 31, 2023	-430.89M
December 31, 2022	-455.41M
September 30, 2022	-488.90M
June 30, 2022	-1.927M

Date	Value
March 31, 2022	-0.048M
December 31, 2021	-0.004M
September 30, 2021	-0.005M
June 30, 2021	-0.02M
March 31, 2021	-0.026M
December 31, 2020	-0.026M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-488.90M

Minimum

Sep 2022

46.02M

Maximum

Sep 2023

-128.72M

Average

-0.026M

Median

Dec 2020

Cash from Investing (TTM) Benchmarks